Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Fecal Immunochemical Testing for Colorectal Cancer Prevention in Two Public Hospitals.

Journal of gastrointestinal cancer·2025
Same author

Fecal Immunochemical Testing for Colorectal Cancer Prevention in Two Public Hospitals.

Journal of gastrointestinal cancer·2025
Same author

Esophageal compression by a common left pulmonary venous trunk.

BJR case reports·2020
Same author

High 30-day readmission rates associated with Clostridiumdifficile infection.

American journal of infection control·2019
Same author

Fidaxomicin and Fecal Microbiota Transplants for Severe Clostridium difficile Colitis.

American journal of therapeutics·2019
Same author

A Decrease of Histone Deacetylase 6 Expression Caused by Helicobacter Pylori Infection is Associated with Oncogenic Transformation in Gastric Cancer.

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology·2017
Same journal

Continuous Glucose Monitoring Metrics and Perinatal Outcomes in Pregnant Women with Type 2 Diabetes.

Diabetes technology & therapeutics·2026
Same journal

Invited Commentary: Using Large Clinical Databases.

Diabetes technology & therapeutics·2026
Same journal

Impact of Technology Introduction on Glycemic Control of People Living with Type 1 Diabetes in Belgium: An Observational, Real-World Study.

Diabetes technology & therapeutics·2026
Same journal

Differences in Achieving Stringent Glycemic Targets Among Youth with Type 1 Diabetes: A SWEET Registry Study.

Diabetes technology & therapeutics·2026
Same journal

<i>Letter:</i> "Nocturnal Hypoglycemia: Characterization with Continuous Glucose Monitoring in a Real-World Setting".

Diabetes technology & therapeutics·2026
Same journal

Transient Benign Ketosis Is Common in Type 1 Diabetes During Very-Low Carbohydrate States: Novel Data from Continuous Ketone Sensor.

Diabetes technology & therapeutics·2026
See all related articles

Related Experiment Video

Updated: Jun 3, 2026

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level
05:35

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level

Published on: January 19, 2024

Developing an objective evaluation method to estimate diabetes risk in community-based settings.

Sonjia Kenya1, Qing He, Robert Fullilove

  • 1St Luke's-Roosevelt Hospital, Columbia University College of Physicians and Surgeons, Columbia University Mailman School of Public Health, New York, New York, USA. skenya@med.miami.edu

Diabetes Technology & Therapeutics
|March 17, 2011
PubMed
Summary
This summary is machine-generated.

Regional bioelectrical impedance analysis (BIA) may better predict glucose levels and assess diabetes risk changes from exercise interventions than whole-body BIA. This objective method improves upon unreliable self-reported data in community settings.

Related Experiment Videos

Last Updated: Jun 3, 2026

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level
05:35

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level

Published on: January 19, 2024

Area of Science:

  • Exercise physiology
  • Metabolic health
  • Biomedical engineering

Background:

  • Exercise interventions target abdominal obesity and glucose tolerance, key type 2 diabetes risk factors.
  • Current assessment methods (questionnaires, whole-body BIA) have limitations like bias and low reliability.
  • Ethnic variations in obesity-diabetes correlations necessitate improved, objective risk assessment methods.

Purpose of the Study:

  • To compare regional bioelectrical impedance analysis (BIA) with whole-body BIA for assessing abdominal obesity.
  • To evaluate regional BIA's ability to predict glucose tolerance.
  • To determine the utility of regional BIA in tracking diabetes risk changes from exercise interventions.

Main Methods:

  • A noninvasive regional BIA technique was compared to whole-body BIA in 39 women.
  • The association between regional BIA measurements and blood glucose levels was analyzed.
  • Multiple regression models incorporated waist circumference and family history to assess glucose prediction.

Main Results:

  • Regional BIA estimates of abdominal fat area strongly correlated with fasting glucose (r = 0.554, P < 0.003).
  • Adding waist circumference and family history to abdominal fat further improved glucose prediction (r = 0.701, P < 0.001).
  • Regional BIA demonstrated potential for objective diabetes risk assessment.

Conclusions:

  • Regional BIA may offer a more accurate prediction of fasting glucose compared to whole-body BIA.
  • This method provides an objective assessment of diabetes risk reduction through exercise interventions in community settings.
  • Regional BIA shows promise for reliable evaluation of exercise program effectiveness.